Peters Susan, Page Matthew J, Coppieters Michel W, Ross Mark, Johnston Venerina
Division of Physiotherapy, School ofHealth and Rehabilitation Sciences, TheUniversity ofQueensland, Brisbane,
Cochrane Database Syst Rev. 2013 Jun 5(6):CD004158. doi: 10.1002/14651858.CD004158.pub2.
Various rehabilitation treatments may be offered following carpal tunnel syndrome (CTS) surgery. The effectiveness of these interventions remains unclear.
To review the effectiveness of rehabilitation following CTS surgery compared with no treatment, placebo, or another intervention.
On 3 April 2012, we searched the Cochrane Neuromuscular Disease Group Specialized Register (3 April 2012), CENTRAL (2012, Issue 3), MEDLINE (January 1966 to March 2012), EMBASE (January 1980 to March 2012), CINAHL Plus (January 1937 to March 2012), AMED (January 1985 to April 2012), LILACS (January 1982 to March 2012), PsycINFO (January 1806 to March 2012), PEDRO (29 January 2013) and clinical trials registers (29 January 2013).
Randomised or quasi-randomised clinical trials that compared any postoperative rehabilitation intervention with either no intervention, placebo or another postoperative rehabilitation intervention in individuals who had undergone CTS surgery.
Two reviewers independently selected trials for inclusion, extracted data and assessed the risk of bias according to standard Cochrane methodology.
In this review we included 20 trials with a total of 1445 participants. We studied different rehabilitation treatments including: immobilisation using a wrist orthosis, dressings, exercise, controlled cold therapy, ice therapy, multimodal hand rehabilitation, laser therapy, electrical modalities, scar desensitisation, and arnica. Three trials compared a rehabilitation treatment to a placebo comparison; three trials compared rehabilitation to a no treatment control; three trials compared rehabilitation to standard care; and 14 trials compared various rehabilitation treatments to one another.Overall, the included studies were very low in quality. Eleven trials explicitly reported random sequence generation and, of these, three adequately concealed the allocation sequence. Four trials achieved blinding of both participants and outcome assessors. Five studies were at high risk of bias from incompleteness of outcome data at one or more time intervals. Eight trials had a high risk of selective reporting bias.The trials were heterogenous in terms of the treatments provided, the duration of interventions, the nature and timing of outcomes measured and setting. Therefore, we were not able to pool results across trials.Four trials reported our primary outcome, change in self reported functional ability at three months or longer. Of these, three trials provided sufficient outcome data for inclusion in this review. One small high quality trial studied a desensitisation program compared to standard treatment and revealed no statistically significant functional benefit based on the Boston Carpal Tunnel Questionnaire (BCTQ) (MD -0.03; 95% CI -0.39 to 0.33). One moderate quality trial assessed participants six months post surgery using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire and found no significant difference between a no formal therapy group and a two-week course of multimodal therapy commenced at five to seven days post surgery (MD 1.00; 95% CI -4.44 to 6.44). One very low quality quasi-randomised trial found no statistically significant difference in function on the BCTQ at three months post surgery with early immobilisation (plaster wrist orthosis worn until suture removal) compared with a splint and late mobilisation (MD 0.39; 95% CI -0.45 to 1.23).The differences between the treatments for the secondary outcome measures (change in self reported functional ability measured at less than three months; change in CTS symptoms; change in CTS-related impairment measures; presence of iatrogenic symptoms from surgery; return to work or occupation; and change in neurophysiological parameters) were generally small and not statistically significant. Few studies reported adverse events.
AUTHORS' CONCLUSIONS: There is limited and, in general, low quality evidence for the benefit of the reviewed interventions. People who have had CTS surgery should be informed about the limited evidence of the effectiveness of postoperative rehabilitation interventions. Until the results of more high quality trials that assess the effectiveness and safety of various rehabilitation treatments have been reported, the decision to provide rehabilitation following CTS surgery should be based on the clinician's expertise, the patient's preferences and the context of the rehabilitation environment. It is important for researchers to identify patients who respond to a certain treatment and those who do not, and to undertake high quality studies that evaluate the severity of iatrogenic symptoms from the surgery, measure function and return-to-work rates, and control for confounding variables.
腕管综合征(CTS)手术后可能会提供各种康复治疗。这些干预措施的有效性尚不清楚。
比较CTS手术后康复治疗与不治疗、安慰剂或其他干预措施的效果。
2012年4月3日,我们检索了Cochrane神经肌肉疾病专业组专门注册库(2012年4月3日)、CENTRAL(2012年第3期)、MEDLINE(1966年1月至2012年3月)、EMBASE(1980年1月至2012年3月)、CINAHL Plus(1937年1月至2012年3月)、AMED(1985年1月至2012年4月)、LILACS(1982年1月至2012年3月)、PsycINFO(1806年1月至2012年3月)、PEDRO(2013年1月29日)和临床试验注册库(2013年1月29日)。
比较任何术后康复干预措施与未干预、安慰剂或其他术后康复干预措施的随机或半随机临床试验,研究对象为接受CTS手术的个体。
两名评价员独立选择纳入试验,提取数据,并根据Cochrane标准方法评估偏倚风险。
本综述纳入20项试验,共1445名参与者。我们研究了不同的康复治疗方法,包括:使用手腕矫形器固定、敷料、运动、控制性冷疗、冰敷、多模式手部康复、激光治疗、电疗法、瘢痕脱敏和山金车属。三项试验将一种康复治疗与安慰剂对照进行比较;三项试验将康复治疗与不治疗对照进行比较;三项试验将康复治疗与标准护理进行比较;14项试验将各种康复治疗方法相互比较。总体而言,纳入研究的质量非常低。11项试验明确报告了随机序列生成,其中三项充分隐藏了分配序列。四项试验实现了参与者和结局评估者的盲法。五项研究因一个或多个时间间隔的结局数据不完整而存在高偏倚风险。八项试验存在选择性报告偏倚的高风险。试验在提供的治疗方法、干预持续时间、测量结局的性质和时间以及研究背景方面存在异质性。因此,我们无法汇总各试验的结果。四项试验报告了我们的主要结局,即三个月或更长时间自我报告的功能能力变化。其中,三项试验提供了足够的结局数据以纳入本综述。一项小型高质量试验研究了脱敏方案与标准治疗的比较,基于波士顿腕管综合征问卷(BCTQ)显示无统计学显著的功能益处(MD -0.03;95%CI -0.39至0.33)。一项中等质量试验在术后六个月使用手臂、肩部和手部功能障碍(DASH)问卷评估参与者,发现未进行正规治疗组与术后五至七天开始的为期两周的多模式治疗组之间无显著差异(MD 1.00;95%CI -4.44至6.44)。一项极低质量的半随机试验发现,与夹板和延迟活动相比,早期固定(术后佩戴石膏手腕矫形器直至拆线)在术后三个月时BCTQ功能上无统计学显著差异(MD 0.39;95%CI -0.45至1.23)。次要结局指标(三个月以内自我报告的功能能力变化;CTS症状变化;CTS相关损伤指标变化;手术引起的医源性症状的存在;重返工作或职业;以及神经生理参数变化)的治疗组间差异通常较小且无统计学显著性。很少有研究报告不良事件。
关于所审查干预措施的益处,证据有限且总体质量较低。应告知接受CTS手术的患者术后康复干预效果的证据有限。在报告更多评估各种康复治疗有效性和安全性的高质量试验结果之前,CTS手术后是否提供康复治疗的决定应基于临床医生的专业知识、患者的偏好以及康复环境的背景。研究人员识别对特定治疗有反应和无反应的患者,并开展高质量研究以评估手术引起的医源性症状的严重程度、测量功能和重返工作率以及控制混杂变量非常重要。